NCT04247984 2022-03-11A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal CancerChineseAMSPhase 2 Completed264 enrolled
NCT04380103 2020-05-08A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal CancerChineseAMSPhase 1/2 Unknown106 enrolled
NCT01679327 2012-09-06Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal CancerChineseAMSPhase 2 Unknown100 enrolled